As of 2024-12-14, the Intrinsic Value of PolyPeptide Group AG (PPGN.SW) is
0.49 CHF. This PPGN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 27.75 CHF, the upside of PolyPeptide Group AG is
-98.20%.
The range of the Intrinsic Value is (0.87) - 8.13 CHF
PPGN.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(0.87) - 8.13 |
0.49 |
-98.2% |
| DCF (Growth 10y) |
9.89 - 71.86 |
19.25 |
-30.6% |
| DCF (EBITDA 5y) |
34.78 - 49.29 |
38.63 |
39.2% |
| DCF (EBITDA 10y) |
46.40 - 73.50 |
54.70 |
97.1% |
| Fair Value |
-4.33 - -4.33 |
-4.33 |
-115.60% |
| P/E |
(29.30) - (33.27) |
(32.08) |
-215.6% |
| EV/EBITDA |
7.07 - 20.91 |
14.01 |
-49.5% |
| EPV |
(8.25) - (11.03) |
(9.64) |
-134.7% |
| DDM - Stable |
(10.06) - (77.30) |
(43.68) |
-257.4% |
| DDM - Multi |
0.24 - 1.64 |
0.44 |
-98.4% |
PPGN.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
915.29 |
| Beta |
1.48 |
| Outstanding shares (mil) |
32.98 |
| Enterprise Value (mil) |
982.63 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.52% |
| Cost of Debt |
7.25% |
| WACC |
7.36% |